Product Information
MEDROL 2 MG TABLET is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $1.5703 per EA under NDC 00009002001. Its NADAC has been published 304 times since Dec 11, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009002001
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLPREDNISOLONEApproval Type
New Drug (NDA)
FDA Application
NDA011153FDA Approved
Before 1982
TE Code
AB
On Market Since
9/20/2013
Pharmacological Classes
Price Statistics
The NADAC for MEDROL 2 MG TABLET has been published 304 times since Dec 11, 2013, and over the history we have for it it has risen 108.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5703 per EA |
|---|---|
| All-time high | $1.5703 (Sep 30, 2026) |
| All-time low | $0.7538 (Dec 11, 2013) |
| 52-week high | $1.5703 |
| 52-week low | $1.5703 |
| Median price | $1.2940 |
| Average price | $1.2491 |
| Largest weekly change | +12.3% (Nov 19, 2014) |
| Weeks tracked | 304 |
| Tracking since | Dec 11, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the methylprednisolone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pharmacia & Upjohn Company LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
methylprednisolone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEDROL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEDROL 2 MG TABLET, manufactured by Pharmacia & Upjohn Company LLC, is $1.5703 per EA (NDC 00009002001), effective Sep 30, 2026.
How has the price of MEDROL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEDROL 2 MG TABLET has risen 108.3%. It has been tracked across 304 weekly CMS publications since Dec 11, 2013.
What are the highest and lowest recorded NADAC prices for MEDROL 2 MG TABLET?
Since Dec 11, 2013, the NADAC for MEDROL 2 MG TABLET has ranged from a low of $0.7538 (Dec 11, 2013) to a high of $1.5703 (Sep 30, 2026), with a median of $1.2940 per EA.
Are there cheaper alternatives to MEDROL 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MEDROL 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEDROL 2 MG TABLET?
MEDROL 2 MG TABLET (NDC 00009002001) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.